Peter Bruno, PhD

Title(s)Assistant Professor, Urology
SchoolSchool of Medicine
Address35 Medical Center Way
San Francisco CA 94143
ORCID ORCID Icon0000-0003-3383-0118 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, San Diego, La Jolla, CAB.S.06/2010Molecular Biology
    Massachusetts Institute of Technology, Cambridge, MAPh.D.06/2016Biology

    Collapse Overview 

    Collapse ORNG Applications 
    Collapse Featured Publications

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. The genomics revolution comes to the immunopeptidome. Genes Immun. 2024 06; 25(3):256-258. Bruno PM. PMID: 38135730; PMCID: PMC11178488.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    2. High-throughput, targeted MHC class I immunopeptidomics using a functional genetics screening platform. Nat Biotechnol. 2023 Jul; 41(7):980-992. Bruno PM, Timms RT, Abdelfattah NS, Leng Y, Lelis FJN, Wesemann DR, Yu XG, Elledge SJ. PMID: 36593401; PMCID: PMC10314971.
      View in: PubMed   Mentions: 6     Fields:    Translation:Cells
    3. Author Correction: Nanoparticle conjugates of a highly potent toxin enhance safety and circumvent platinum resistance in ovarian cancer. Nat Commun. 2020 Apr 17; 11(1):1940. Qi R, Wang Y, Bruno PM, Xiao H, Yu Y, Li T, Lauffer S, Wei W, Chen Q, Kang X, Song H, Yang X, Huang X, Detappe A, Matulonis U, Pepin D, Hemann MT, Birrer MJ, Ghoroghchian PP. PMID: 32303677; PMCID: PMC7165165.
      View in: PubMed   Mentions: 1     Fields:    
    4. The primary mechanism of cytotoxicity of the chemotherapeutic agent CX-5461 is topoisomerase II poisoning. Proc Natl Acad Sci U S A. 2020 02 25; 117(8):4053-4060. Bruno PM, Lu M, Dennis KA, Inam H, Moore CJ, Sheehe J, Elledge SJ, Hemann MT, Pritchard JR. PMID: 32041867; PMCID: PMC7049172.
      View in: PubMed   Mentions: 60     Fields:    Translation:HumansCells
    5. Publisher Correction: Nanoparticle conjugates of a highly potent toxin enhance safety and circumvent platinum resistance in ovarian cancer. Nat Commun. 2018 02 07; 9(1):628. Qi R, Wang Y, Bruno PM, Xiao H, Yu Y, Li T, Lauffer S, Wei W, Chen Q, Kang X, Song H, Yang X, Huang X, Detappe A, Matulonis U, Pepin D, Hemann MT, Birrer MJ, Ghoroghchian PP. PMID: 29416025; PMCID: PMC5803230.
      View in: PubMed   Mentions:    Fields:    
    6. Nanoparticle conjugates of a highly potent toxin enhance safety and circumvent platinum resistance in ovarian cancer. Nat Commun. 2017 12 18; 8(1):2166. Qi R, Wang Y, Bruno PM, Xiao H, Yu Y, Li T, Lauffer S, Wei W, Chen Q, Kang X, Song H, Yang X, Huang X, Detappe A, Matulonis U, Pepin D, Hemann MT, Birrer MJ, Ghoroghchian PP. PMID: 29255160; PMCID: PMC5735131.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansAnimalsCells
    7. Aneuploid Cell Survival Relies upon Sphingolipid Homeostasis. Cancer Res. 2017 10 01; 77(19):5272-5286. Tang YC, Yuwen H, Wang K, Bruno PM, Bullock K, Deik A, Santaguida S, Trakala M, Pfau SJ, Zhong N, Huang T, Wang L, Clish CB, Hemann MT, Amon A. PMID: 28775166; PMCID: PMC5772763.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansAnimalsCells
    8. Induction of Necroptosis in Cancer Stem Cells using a Nickel(II)-Dithiocarbamate Phenanthroline Complex. Chemistry. 2017 Jul 18; 23(40):9674-9682. Flamme M, Cressey PB, Lu C, Bruno PM, Eskandari A, Hemann MT, Hogarth G, Suntharalingam K. PMID: 28556445.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    9. A subset of platinum-containing chemotherapeutic agents kills cells by inducing ribosome biogenesis stress. Nat Med. 2017 Apr; 23(4):461-471. Bruno PM, Liu Y, Park GY, Murai J, Koch CE, Eisen TJ, Pritchard JR, Pommier Y, Lippard SJ, Hemann MT. PMID: 28263311; PMCID: PMC5520548.
      View in: PubMed   Mentions: 182     Fields:    Translation:HumansAnimalsCells
    10. The breast cancer stem cell potency of copper(ii) complexes bearing nonsteroidal anti-inflammatory drugs and their encapsulation using polymeric nanoparticles. Dalton Trans. 2016 Nov 28; 45(44):17867-17873. Eskandari A, Boodram JN, Cressey PB, Lu C, Bruno PM, Hemann MT, Suntharalingam K. PMID: 27774561.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    11. Using an RNAi Signature Assay To Guide the Design of Three-Drug-Conjugated Nanoparticles with Validated Mechanisms, In Vivo Efficacy, and Low Toxicity. J Am Chem Soc. 2016 09 28; 138(38):12494-501. Barnes JC, Bruno PM, Nguyen HV, Liao L, Liu J, Hemann MT, Johnson JA. PMID: 27626288; PMCID: PMC5597434.
      View in: PubMed   Mentions: 16     Fields:    Translation:AnimalsCells
    12. The Potent Inhibitory Effect of a Naproxen-Appended Cobalt(III)-Cyclam Complex on Cancer Stem Cells. Chembiochem. 2016 09 15; 17(18):1713-8. Cressey PB, Eskandari A, Bruno PM, Lu C, Hemann MT, Suntharalingam K. PMID: 27377813.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    13. Versatile in vivo regulation of tumor phenotypes by dCas9-mediated transcriptional perturbation. Proc Natl Acad Sci U S A. 2016 07 05; 113(27):E3892-900. Braun CJ, Bruno PM, Horlbeck MA, Gilbert LA, Weissman JS, Hemann MT. PMID: 27325776; PMCID: PMC4941480.
      View in: PubMed   Mentions: 47     Fields:    Translation:Animals
    14. Mechanistic Studies of the Anticancer Activity of An Octahedral Hexanuclear Pt(II) Cage. Inorganica Chim Acta. 2016 Oct 01; 452:125-129. Zheng YR, Suntharalingam K, Bruno PM, Lin W, Wang W, Hemann MT, Lippard SJ. PMID: 27818526; PMCID: PMC5094802.
      View in: PubMed   Mentions: 10  
    15. Correction to "A Pt(IV) Pro-drug Preferentially Targets Indoleamine-2,3-dioxygenase, Providing Enhanced Ovarian Cancer Immuno-Chemotherapy". J Am Chem Soc. 2016 Mar 09; 138(9):3250. Awuah SG, Zheng YR, Bruno PM, Hemann MT, Lippard SJ. PMID: 26916820.
      View in: PubMed   Mentions:    Fields:    
    16. Breast Cancer Stem Cell Potent Copper(II)-Non-Steroidal Anti-Inflammatory Drug Complexes. Angew Chem Int Ed Engl. 2016 Feb 18; 55(8):2845-50. Boodram JN, Mcgregor IJ, Bruno PM, Cressey PB, Hemann MT, Suntharalingam K. PMID: 26806362.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    17. A Pt(IV) Pro-drug Preferentially Targets Indoleamine-2,3-dioxygenase, Providing Enhanced Ovarian Cancer Immuno-Chemotherapy. J Am Chem Soc. 2015 Dec 02; 137(47):14854-7. Awuah SG, Zheng YR, Bruno PM, Hemann MT, Lippard SJ. PMID: 26561720; PMCID: PMC4772771.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    18. Necroptosis-inducing rhenium(V) oxo complexes. J Am Chem Soc. 2015 Mar 04; 137(8):2967-74. Suntharalingam K, Awuah SG, Bruno PM, Johnstone TC, Wang F, Lin W, Zheng YR, Page JE, Hemann MT, Lippard SJ. PMID: 25698398; PMCID: PMC4702498.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansAnimalsCells
    19. A breast cancer stem cell-selective, mammospheres-potent osmium(VI) nitrido complex. J Am Chem Soc. 2014 Oct 15; 136(41):14413-6. Suntharalingam K, Lin W, Johnstone TC, Bruno PM, Zheng YR, Hemann MT, Lippard SJ. PMID: 25247635; PMCID: PMC4210142.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    20. Bidentate ligands on osmium(VI) nitrido complexes control intracellular targeting and cell death pathways. J Am Chem Soc. 2013 Sep 25; 135(38):14060-3. Suntharalingam K, Johnstone TC, Bruno PM, Lin W, Hemann MT, Lippard SJ. PMID: 24041161; PMCID: PMC3791136.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCells
    21. Predicting cancer drug mechanisms of action using molecular network signatures. Mol Biosyst. 2013 Jul; 9(7):1604-19. Pritchard JR, Bruno PM, Hemann MT, Lauffenburger DA. PMID: 23287973; PMCID: PMC3945388.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    22. Defining principles of combination drug mechanisms of action. Proc Natl Acad Sci U S A. 2013 Jan 08; 110(2):E170-9. Pritchard JR, Bruno PM, Gilbert LA, Capron KL, Lauffenburger DA, Hemann MT. PMID: 23251029; PMCID: PMC3545813.
      View in: PubMed   Mentions: 78     Fields:    Translation:HumansAnimals
    Peter's Networks
    Concepts (131)
    Derived automatically from this person's publications.
    _
    Co-Authors (2)
    People in Profiles who have published with this person.
    _
    Similar People (59)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _